Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C25H21BrF3N4O4S.K |
| Molecular Weight | 649.521 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[K+].CCC1=NC(C2CC2)=C(N1CC3=CC4=C(OC(=C4Br)C5=CC=CC=C5[N-]S(=O)(=O)C(F)(F)F)C=C3)C(N)=O
InChI
InChIKey=IASZJGRIPLTJMA-UHFFFAOYSA-N
InChI=1S/C25H21BrF3N4O4S.K/c1-2-19-31-21(14-8-9-14)22(24(30)34)33(19)12-13-7-10-18-16(11-13)20(26)23(37-18)15-5-3-4-6-17(15)32-38(35,36)25(27,28)29;/h3-7,10-11,14H,2,8-9,12H2,1H3,(H2,30,34);/q-1;+1
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: P30556 Gene ID: 185.0 Gene Symbol: AGTR1 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/7853190 |
PubMed
| Title | Date | PubMed |
|---|---|---|
| The antihypertensive profile of the angiotensin AT1 receptor antagonist, GR138950, and the influence of potential homeostatic compensatory mechanisms in renal hypertensive rats. | 1998-11 |
|
| Investigation of the inhibitory effect of N(G)-nitro-L-arginine methyl ester on the antihypertensive effect of the angiotensin AT1 receptor antagonist, GR138950. | 1997-12 |
|
| Pharmacological effects of GR138950, a novel angiotensin AT1 receptor antagonist. | 1995-02 |
|
| Bromobenzofuran-based non-peptide antagonists of angiotensin II: GR138950, a potent antihypertensive agent with high oral bioavailability. | 1994-09-16 |
Patents
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C66930
Created by
admin on Mon Mar 31 18:14:27 GMT 2025 , Edited by admin on Mon Mar 31 18:14:27 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
GG-106
Created by
admin on Mon Mar 31 18:14:27 GMT 2025 , Edited by admin on Mon Mar 31 18:14:27 GMT 2025
|
PRIMARY | |||
|
DTXSID40163421
Created by
admin on Mon Mar 31 18:14:27 GMT 2025 , Edited by admin on Mon Mar 31 18:14:27 GMT 2025
|
PRIMARY | |||
|
23678978
Created by
admin on Mon Mar 31 18:14:27 GMT 2025 , Edited by admin on Mon Mar 31 18:14:27 GMT 2025
|
PRIMARY | |||
|
CHEMBL305544
Created by
admin on Mon Mar 31 18:14:27 GMT 2025 , Edited by admin on Mon Mar 31 18:14:27 GMT 2025
|
PRIMARY | |||
|
DBSALT001863
Created by
admin on Mon Mar 31 18:14:27 GMT 2025 , Edited by admin on Mon Mar 31 18:14:27 GMT 2025
|
PRIMARY | |||
|
146613-90-3
Created by
admin on Mon Mar 31 18:14:27 GMT 2025 , Edited by admin on Mon Mar 31 18:14:27 GMT 2025
|
PRIMARY | |||
|
100000084945
Created by
admin on Mon Mar 31 18:14:27 GMT 2025 , Edited by admin on Mon Mar 31 18:14:27 GMT 2025
|
PRIMARY | |||
|
T28707PG7T
Created by
admin on Mon Mar 31 18:14:27 GMT 2025 , Edited by admin on Mon Mar 31 18:14:27 GMT 2025
|
PRIMARY | |||
|
C152298
Created by
admin on Mon Mar 31 18:14:27 GMT 2025 , Edited by admin on Mon Mar 31 18:14:27 GMT 2025
|
PRIMARY | |||
|
C089586
Created by
admin on Mon Mar 31 18:14:27 GMT 2025 , Edited by admin on Mon Mar 31 18:14:27 GMT 2025
|
PRIMARY | |||
|
SUB04326MIG
Created by
admin on Mon Mar 31 18:14:27 GMT 2025 , Edited by admin on Mon Mar 31 18:14:27 GMT 2025
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD